Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 14, 2018; 24(26): 2878-2885
Published online Jul 14, 2018. doi: 10.3748/wjg.v24.i26.2878
Published online Jul 14, 2018. doi: 10.3748/wjg.v24.i26.2878
Table 1 Baseline characteristics of 311 lesions treated with endoscopic submucosal tunnel dissection n (%)
| Category | ESTD (n = 311) |
| Sex, male/female | 213/98 |
| Age, yr, mean (range) | 61.4 ± 8.1 (40-83) |
| Tumor location | |
| Upper third | 24 (7.72) |
| Middle third | 200 (64.31) |
| Lower third | 87 (27.97) |
| Paris classification | |
| 0-I | 18 (5.79) |
| 0-IIa | 111 (35.69) |
| 0-IIb | 94 (30.23) |
| 0-IIc | 35 (11.25) |
| 0-IIa-IIc | 50 (16.08) |
| 0-III | 3 (0.96) |
| Circumferential level | |
| ≤ 1/4 | 11 (3.54) |
| ≤ 1/2 | 163 (52.41) |
| ≤ 3/4 | 65 (20.90) |
| ≤ 7/8 | 41 (13.18) |
| ≤ 1 | 31 (9.97) |
- Citation: Wang J, Zhu XN, Zhu LL, Chen W, Ma YH, Gan T, Yang JL. Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma and precancerous lesions. World J Gastroenterol 2018; 24(26): 2878-2885
- URL: https://www.wjgnet.com/1007-9327/full/v24/i26/2878.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i26.2878